31.47
1.07 (3.52%)
1.07 (3.52%)
Upgrade to Real-Time
Afterhours
Low
28.00
High
74.89
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BioXcel Therapeutics Inc | BTAI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 1.07 | 3.52% | 31.47 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 30.40 | 30.125 | 31.50 | 31.47 | 30.40 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 30.75 | 31.40 | 0.65 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,695 | 480,290 | $ 30.86 | $ 14,823,040 | 433,598 | 28.00 - 74.89 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:41:22 | 1 | $ 31.47 | USD |
BioXcel Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 775.17M | 24.63M | 15.15M | $ - | $ - | -3.77 | -8.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -1.10M | 0.70% |
BioXcel Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BTAI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 31.03 | 33.86 | 28.00 | 31.44 | 405,186 | 0.44 | 1.42% |
| 1 Month | 35.06 | 36.35 | 28.00 | 32.99 | 337,722 | -3.59 | -10.24% |
| 3 Months | 56.215 | 60.36 | 28.00 | 40.95 | 462,301 | -24.75 | -44.02% |
| 6 Months | 55.00 | 67.74 | 28.00 | 46.27 | 490,929 | -23.53 | -42.78% |
| 1 Year | 42.06 | 74.89 | 28.00 | 47.45 | 531,606 | -10.59 | -25.18% |
| 3 Years | 9.99 | 74.89 | 2.41 | 36.89 | 293,436 | 21.48 | 215.02% |
| 5 Years | 11.02 | 74.89 | 2.41 | 36.38 | 282,232 | 20.45 | 185.57% |
BioXcel Therapeutics Description
| BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701. |
